Trexquant Investment LP Provention Bio, Inc. Transaction History

Trexquant Investment LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$3.4 - $7.88 $137,876 - $319,549	-40,552 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.59 - $7.39 $144,887 - $191,541	25,919 Added 177.13%	40,552 $228,000
Q3 2021 Nov 12, 2021	BUY	$5.66 - $8.33 $82,822 - $121,892	14,633 New	14,633 $94,000
Q2 2021 Aug 12, 2021	SELL	$6.71 - $11.04 $143,332 - $235,825	-21,361 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$10.12 - $19.45 $216,173 - $415,471	21,361 New	21,361 $224,000
Q4 2020 Feb 11, 2021	SELL	$11.79 - $18.94 $178,076 - $286,069	-15,104 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$10.34 - $15.2 $156,175 - $229,580	15,104 New	15,104 $194,000
Q2 2020 Aug 07, 2020	SELL	$7.81 - $17.0 $207,824 - $452,370	-26,610 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$5.42 - $17.75 $144,226 - $472,327	26,610 New	26,610 $245,000

170K

Ticker PRVB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,549,904
Description
Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.